Skip to main content
. 2021 Mar 18;16:701–713. doi: 10.2147/COPD.S297943

Figure 6.

Figure 6

Total direct costs excluding drug costs (A) and costs for drugs in COPD patients (B) with 0, 1 and ≥2 exacerbations per year during 11 years of follow-up.